BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 21 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $110,000 | +8.9% | 43,293 | +3.5% | 0.00% | – |
| Q3 2016 | $101,000 | 0.0% | 41,829 | +0.0% | 0.00% | – |
| Q2 2016 | $101,000 | -11.4% | 41,811 | -1.7% | 0.00% | – |
| Q1 2016 | $114,000 | -13.0% | 42,519 | -7.1% | 0.00% | – |
| Q4 2015 | $131,000 | +31.0% | 45,756 | +4.7% | 0.00% | – |
| Q3 2015 | $100,000 | -38.3% | 43,702 | -2.6% | 0.00% | – |
| Q2 2015 | $162,000 | – | 44,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
| ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
| CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
| Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
| Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
| WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
| IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |